2024 annual financial data
Bionano Genomics 2024 Operating margin
Direct answer
Operating margin was -337.87%.
Operating income was -103,983,000 USD and net income was -112,017,000 USD.
Operating cash flow was -68,922,000 USD.
Get free Bionano Genomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 30,776,000 USD
- Operating income
- -103,983,000 USD
- Net income
- -112,017,000 USD
- Operating cash flow
- -68,922,000 USD